Canadian MDL granted for dry eye test
August 31st 2011The maker of an in-office test (InflammaDry Detector, Rapid Pathogen Screening) to detect elevated levels of matrix metalloproteinase-9 (MMP?9) in tear fluid expects to begin marketing it in Canada soon now that the company has been granted a medical device license from Health Canada. The product was also recently released in Europe and Asia.
FDA extends aflibercept review
August 24th 2011The FDA has extended by 3 months its target date to complete a priority review of the biologics license application (BLA) of aflibercept injection for intravitreal use (Eylea, also known as VEGF Trap-Eye, Regeneron Pharmaceuticals) for the treatment of neovascular age-related macular degeneration (AMD) to Nov. 18.
'BioCube' searches for allergy relief
August 17th 2011Ora Inc. is expanding its internal research efforts to include the development of a nasal allergen challenge model, as well as a new Allergen BioCube (ABC) system that can be used for evaluating anti-allergy drugs administered via both ocular and nasal routes.
August: Children's eye health month
August 17th 2011With the approach of the school year, Prevent Blindness America (PBA) has declared August as Children's Eye Health and Safety Awareness month, and is encouraging parents to ?make sure every child takes the test that may help them pass all the rest.?